118 related articles for article (PubMed ID: 3452285)
1. Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
Scarffe JH; Wagstaff J; Crowther D
Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285
[No Abstract] [Full Text] [Related]
2. INTRON A (interferon alfa-2b): clinical overview.
Spiegel RJ
Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
[No Abstract] [Full Text] [Related]
3. [Interferons in cancerology. Focus in 1988].
Boiron M
Pathol Biol (Paris); 1989 Feb; 37(2):92-3. PubMed ID: 2652080
[No Abstract] [Full Text] [Related]
4. [Clinical use of alpha-interferon in onco-hematology: conclusions and prospects].
Bernasconi C
Haematologica; 1990; 75 Suppl 4():82-4. PubMed ID: 2074058
[No Abstract] [Full Text] [Related]
5. Alfa interferon: combinations with other antineoplastic modalities.
Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
[TBL] [Abstract][Full Text] [Related]
6. Intron A (interferon alfa-2b): clinical overview and future directions.
Spiegel RJ
Semin Oncol; 1986 Sep; 13(3 Suppl 2):89-101. PubMed ID: 3532338
[TBL] [Abstract][Full Text] [Related]
7. Interferons in the treatment of multiple myeloma.
Cooper MR
Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
Vonderheid EC; Thompson R; Smiles KA; Lattanand A
Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
[TBL] [Abstract][Full Text] [Related]
9. Interferons and cancer therapy.
Priestman TJ
J Pathol; 1983 Nov; 141(3):287-95. PubMed ID: 6363649
[TBL] [Abstract][Full Text] [Related]
10. Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
Rohatiner AZ; Richards MA; Barnett MJ; Stansfeld AG; Lister TA
Br J Cancer; 1987 Feb; 55(2):225-6. PubMed ID: 3814493
[No Abstract] [Full Text] [Related]
11. [Effects of interferon on various malignancies].
Taguchi T
Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
Chisesi T; Capnist G; Vespignani M; Cetto G
Invest New Drugs; 1987; 5 Suppl():S35-40. PubMed ID: 3298132
[TBL] [Abstract][Full Text] [Related]
13. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
14. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
Chisesi T; Capnist G; Vespignani M; Dini E
Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691
[No Abstract] [Full Text] [Related]
15. Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
Mandelli F; Tribalto M; Avvisati G; Cantonetti M; Petrucci MT; Boccadoro M; Pileri A; Marmont F; Resegotti L; Lauta V
Cancer Treat Rev; 1988 Jan; 15 Suppl A():43-8. PubMed ID: 3277709
[No Abstract] [Full Text] [Related]
16. Urinary enzyme excretion during treatment of malignancies with human recombinant alpha-2 interferon.
Metz-Kurschel U; Kurschel E; Niederle N; Scheulen ME; Graben N
Nephrol Dial Transplant; 1987; 2(6):515-9. PubMed ID: 2894618
[No Abstract] [Full Text] [Related]
17. Recombinant alpha interferons 1986: a review.
Lindquist DL; Burns CP
Iowa Med; 1987 Jan; 77(1):32, 34, 36. PubMed ID: 3818250
[No Abstract] [Full Text] [Related]
18. Strategies for the integration of Intron A (interferon alfa-2b) into the treatment of hematological malignancies. Proceedings of a satellite symposium at the Third International Conference on Malignant Lymphoma. Lugano June 1987.
Cancer Treat Rev; 1988 Jan; 15 Suppl A():1-65. PubMed ID: 3342416
[No Abstract] [Full Text] [Related]
19. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase.
Case DC; Sonneborn HL; Paul SD; Hiebel J; Boyd MA; Shepp MA; Dorsk BM; Bonnem E
Cancer Treat Rep; 1986 Nov; 70(11):1251-4. PubMed ID: 3768870
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies].
Imamura Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):934-41. PubMed ID: 3694002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
